{"transactions":[{"id":1467931,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2024-06-27T20:09:27.000Z","date":"2024-06-25","kind":"exercise","planned":false,"acquired":false,"shares":18250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":36500,"derivative":{"underlying":"American Depositary Shares","underlying_shares":18250},"source":{"system":"sec-edgar","filing":"0000905148-24-001804","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001804/form4.xml","form_type":"4"}},{"id":1467930,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-06-27T20:09:27.000Z","date":"2024-06-26","kind":"sale","planned":false,"acquired":false,"shares":7431,"price":17.901,"value":133022.331,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F4","text":"These ADSs were sold automatically to cover taxes upon vesting of RSUs."}],"balance_after":62619,"source":{"system":"sec-edgar","filing":"0000905148-24-001804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001804/form4.xml","form_type":"4"}},{"id":1467929,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-06-27T20:09:27.000Z","date":"2024-06-25","kind":"exercise","planned":false,"acquired":true,"shares":18250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired upon vesting of Restricted Share Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."}],"balance_after":70050,"source":{"system":"sec-edgar","filing":"0000905148-24-001804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001804/form4.xml","form_type":"4"}},{"id":1546399,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2024-04-05T21:48:35.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":false,"shares":5270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":15811,"derivative":{"underlying":"American Depositary Shares","underlying_shares":5270},"source":{"system":"sec-edgar","filing":"0000905148-24-001113","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001113/form4.xml","form_type":"4"}},{"id":1546398,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-04-05T21:48:35.000Z","date":"2024-04-04","kind":"sale","planned":false,"acquired":false,"shares":2105,"price":15.673,"value":32991.665,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F3","text":"These ADSs were sold automatically to cover taxes upon vesting of RSUs."}],"balance_after":51800,"source":{"system":"sec-edgar","filing":"0000905148-24-001113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001113/form4.xml","form_type":"4"}},{"id":1546397,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-04-05T21:48:35.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":true,"shares":5270,"price":15.9,"value":83793.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired upon vesting of Restricted Share Units (\"RSUs\")."}],"balance_after":53905,"source":{"system":"sec-edgar","filing":"0000905148-24-001113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001113/form4.xml","form_type":"4"}},{"id":1548505,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2024-04-04T01:45:08.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":false,"shares":1010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Restricted Share Unit (\"RSU\") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":2020,"derivative":{"underlying":"American Depositary Shares","underlying_shares":1010},"source":{"system":"sec-edgar","filing":"0000905148-24-001094","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001094/form4.xml","form_type":"4"}},{"id":1548504,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2024-04-04T01:45:08.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":false,"shares":3338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Restricted Share Unit (\"RSU\") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":10016,"derivative":{"underlying":"American Depositary Shares","underlying_shares":3338},"source":{"system":"sec-edgar","filing":"0000905148-24-001094","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001094/form4.xml","form_type":"4"}},{"id":1548503,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2024-04-04T01:45:08.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":69758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Restricted Share Unit (\"RSU\") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":69758,"derivative":{"underlying":"American Depositary Shares","underlying_shares":69758},"source":{"system":"sec-edgar","filing":"0000905148-24-001094","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001094/form4.xml","form_type":"4"}},{"id":1548502,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-04-04T01:45:08.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":107321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each Stock Option is exercisable for one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":107321,"derivative":{"exercise_price":16.72,"expiration_date":"2034-04-01","underlying":"American Depositary Shares","underlying_shares":107321},"source":{"system":"sec-edgar","filing":"0000905148-24-001094","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001094/form4.xml","form_type":"4"}},{"id":1548501,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-04-04T01:45:08.000Z","date":"2024-04-02","kind":"sale","planned":false,"acquired":false,"shares":413,"price":16.151,"value":6670.363,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F3","text":"These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units."}],"balance_after":48635,"source":{"system":"sec-edgar","filing":"0000905148-24-001094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001094/form4.xml","form_type":"4"}},{"id":1548500,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-04-04T01:45:08.000Z","date":"2024-04-02","kind":"sale","planned":false,"acquired":false,"shares":1360,"price":16.151,"value":21965.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F3","text":"These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units."}],"balance_after":49048,"source":{"system":"sec-edgar","filing":"0000905148-24-001094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001094/form4.xml","form_type":"4"}},{"id":1548499,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-04-04T01:45:08.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":true,"shares":1010,"price":16.72,"value":16887.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired on vesting of Restricted Share Units."}],"balance_after":50408,"source":{"system":"sec-edgar","filing":"0000905148-24-001094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001094/form4.xml","form_type":"4"}},{"id":1548498,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-04-04T01:45:08.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":true,"shares":3338,"price":16.72,"value":55811.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired on vesting of Restricted Share Units."}],"balance_after":49398,"source":{"system":"sec-edgar","filing":"0000905148-24-001094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824001094/form4.xml","form_type":"4"}},{"id":1690699,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Performance-Based Share Units","published_at":"2024-01-04T00:25:23.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":false,"shares":17548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PSU represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted PSUs on December 1, 2021 that vest based on the satisfaction of specified performance criteria between December 1, 2021 and December 31, 2025. On January 1, 2024, the performance-based vesting conditions were confirmed for PSUs representing 17,548 ADSs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The reporting person was granted PSUs on December 1, 2021 that vest based on the satisfaction of specified performance criteria between December 1, 2021 and December 31, 2025. On January 1, 2024, the performance-based vesting conditions were confirmed for PSUs representing 17,548 ADSs."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":0,"derivative":{"underlying":"American Depositary Shares","underlying_shares":17548},"source":{"system":"sec-edgar","filing":"0000905148-24-000061","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824000061/form4.xml","form_type":"4"}},{"id":1690698,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Performance-Based Share Units","published_at":"2024-01-04T00:25:23.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":17548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PSU represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted PSUs on December 1, 2021 that vest based on the satisfaction of specified performance criteria between December 1, 2021 and December 31, 2025. On January 1, 2024, the performance-based vesting conditions were confirmed for PSUs representing 17,548 ADSs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The reporting person was granted PSUs on December 1, 2021 that vest based on the satisfaction of specified performance criteria between December 1, 2021 and December 31, 2025. On January 1, 2024, the performance-based vesting conditions were confirmed for PSUs representing 17,548 ADSs."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":17548,"derivative":{"underlying":"American Depositary Shares","underlying_shares":17548},"source":{"system":"sec-edgar","filing":"0000905148-24-000061","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824000061/form4.xml","form_type":"4"}},{"id":1690697,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-01-04T00:25:23.000Z","date":"2024-01-03","kind":"sale","planned":false,"acquired":false,"shares":4803,"price":26.122,"value":125463.966,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F4","text":"These ADSs were sold automatically to cover taxes upon vesting of PSUs."}],"balance_after":46060,"source":{"system":"sec-edgar","filing":"0000905148-24-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824000061/form4.xml","form_type":"4"}},{"id":1690696,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-01-04T00:25:23.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":true,"shares":17548,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired on vesting of performance-based share units (PSUs). Each ADS represents ten Ordinary Shares of the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each PSU represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."}],"balance_after":50863,"source":{"system":"sec-edgar","filing":"0000905148-24-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000090514824000061/form4.xml","form_type":"4"}},{"id":1844009,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2023-06-26T20:07:51.000Z","date":"2023-06-23","kind":"exercise","planned":false,"acquired":false,"shares":18250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":54750,"derivative":{"exercise_price":0,"underlying":"American Depositary Shares","underlying_shares":18250},"source":{"system":"sec-edgar","filing":"0000950170-23-029861","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000095017023029861/ownership.xml","form_type":"4"}},{"id":1844008,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2023-06-26T20:07:51.000Z","date":"2023-06-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":7182,"price":25.3,"value":181704.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction represents the disposition of shares to cover taxes."}],"balance_after":33315,"source":{"system":"sec-edgar","filing":"0000950170-23-029861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000095017023029861/ownership.xml","form_type":"4"}},{"id":1844007,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2023-06-26T20:07:51.000Z","date":"2023-06-23","kind":"exercise","planned":false,"acquired":true,"shares":18250,"price":25.3,"value":461725.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer."}],"balance_after":40497,"source":{"system":"sec-edgar","filing":"0000950170-23-029861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000095017023029861/ownership.xml","form_type":"4"}},{"id":1924518,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2023-04-05T20:05:24.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":21081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Share Units vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Share Units vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each ADS represents ten Ordinary Shares of the issuer."}],"balance_after":21081,"derivative":{"underlying":"American Depositary Shares","underlying_shares":21081},"source":{"system":"sec-edgar","filing":"0000899243-23-010712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323010712/doc4.xml","form_type":"4"}},{"id":1924517,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-04-05T20:05:24.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":109632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Stock Options are exercisable for American Depositary Shares (ADSs). The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Options vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each ADS represents ten Ordinary Shares of the issuer."}],"balance_after":109632,"derivative":{"exercise_price":33.95,"expiration_date":"2033-04-03","underlying":"American Depositary Shares","underlying_shares":109632},"source":{"system":"sec-edgar","filing":"0000899243-23-010712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323010712/doc4.xml","form_type":"4"}},{"id":1931775,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2023-04-03T20:05:14.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":1010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":3030,"derivative":{"underlying":"American Depositary Shares","underlying_shares":1010},"source":{"system":"sec-edgar","filing":"0000899243-23-010212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323010212/doc4.xml","form_type":"4"}},{"id":1931774,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2023-04-03T20:05:14.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":3338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":13354,"derivative":{"underlying":"American Depositary Shares","underlying_shares":3338},"source":{"system":"sec-edgar","filing":"0000899243-23-010212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323010212/doc4.xml","form_type":"4"}},{"id":1931773,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2023-04-03T20:05:14.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":813,"price":33.26,"value":27040.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction represents the disposition of shares to cover taxes."}],"balance_after":22247,"source":{"system":"sec-edgar","filing":"0000899243-23-010212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323010212/doc4.xml","form_type":"4"}},{"id":1931772,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2023-04-03T20:05:14.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":3338,"price":33.26,"value":111021.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer."}],"balance_after":23060,"source":{"system":"sec-edgar","filing":"0000899243-23-010212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323010212/doc4.xml","form_type":"4"}},{"id":1931771,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2023-04-03T20:05:14.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":246,"price":33.26,"value":8181.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction represents the disposition of shares to cover taxes."}],"balance_after":19722,"source":{"system":"sec-edgar","filing":"0000899243-23-010212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323010212/doc4.xml","form_type":"4"}},{"id":1931770,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2023-04-03T20:05:14.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":1010,"price":33.26,"value":33592.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer."}],"balance_after":19968,"source":{"system":"sec-edgar","filing":"0000899243-23-010212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323010212/doc4.xml","form_type":"4"}},{"id":1964885,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-07T21:05:19.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":11480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 08/23/2022, that expires on 06/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in equal installments over four years beginning on 5/12/2018, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":3,"expiration_date":"2027-05-12","underlying":"American Depositary Shares","underlying_shares":11480},"source":{"system":"sec-edgar","filing":"0000899243-23-007331","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323007331/doc4.xml","form_type":"4"}},{"id":1964884,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2023-03-07T21:05:19.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":11480,"price":40,"value":459200.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 08/23/2022, that expires on 06/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":18958,"source":{"system":"sec-edgar","filing":"0000899243-23-007331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323007331/doc4.xml","form_type":"4"}},{"id":1964883,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2023-03-07T21:05:19.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":11480,"price":3,"value":34440.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 08/23/2022, that expires on 06/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":30438,"source":{"system":"sec-edgar","filing":"0000899243-23-007331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323007331/doc4.xml","form_type":"4"}},{"id":2072041,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2023-01-03T21:05:13.000Z","date":"2022-12-30","kind":"tax_withholding","acquired":false,"shares":5903,"price":30.7,"value":181222.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were disposed of through a netting transaction to the issuer to cover taxes due."}],"balance_after":18958,"source":{"system":"sec-edgar","filing":"0000899243-23-000205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924323000205/doc4.xml","form_type":"4"}},{"id":2111472,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-11-18T02:37:33.000Z","date":"2022-11-15","kind":"exercise","acquired":false,"shares":1854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were disposed of through a netting transaction to the issuer to cover taxes due. Due to an inadvertent administrative error, the disposition of such shares to cover taxes was not reported on the original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares were disposed of through a netting transaction to the issuer to cover taxes due. Due to an inadvertent administrative error, the disposition of such shares to cover taxes was not reported on the original Form 4."}],"balance_after":11480,"derivative":{"exercise_price":3,"expiration_date":"2027-05-12","underlying":"American Depositary Shares","underlying_shares":1854},"source":{"system":"sec-edgar","filing":"0000899243-22-036308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924322036308/doc4.xml","form_type":"4"}},{"id":2111471,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2022-11-18T02:37:33.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":100,"price":40.03,"value":4003.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 8/23/2022, expires 6/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":24861,"source":{"system":"sec-edgar","filing":"0000899243-22-036308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924322036308/doc4.xml","form_type":"4"}},{"id":2111470,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2022-11-18T02:37:33.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":1754,"price":40,"value":70160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 8/23/2022, expires 6/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":24961,"source":{"system":"sec-edgar","filing":"0000899243-22-036308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924322036308/doc4.xml","form_type":"4"}},{"id":2111469,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2022-11-18T02:37:33.000Z","date":"2022-11-15","kind":"exercise","acquired":true,"shares":1854,"price":3,"value":5562.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 8/23/2022, expires 6/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":26715,"source":{"system":"sec-edgar","filing":"0000899243-22-036308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924322036308/doc4.xml","form_type":"4"}},{"id":2111468,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2022-11-18T02:37:33.000Z","date":"2022-04-01","kind":"tax_withholding","acquired":false,"shares":246,"price":45.47,"value":11185.62,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer."},{"field":"security","element":"securityTitle","label":"F2","text":"The shares were disposed of through a netting transaction to the issuer to cover taxes due. Due to an inadvertent administrative error, the disposition of such shares to cover taxes was not reported on the original Form 4."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were disposed of through a netting transaction to the issuer to cover taxes due. Due to an inadvertent administrative error, the disposition of such shares to cover taxes was not reported on the original Form 4."}],"balance_after":24861,"source":{"system":"sec-edgar","filing":"0000899243-22-036308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924322036308/doc4.xml","form_type":"4"}},{"id":2220842,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2022-06-28T01:42:03.000Z","date":"2022-06-25","kind":"grant","acquired":true,"shares":73000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."}],"balance_after":73000,"derivative":{"underlying":"American Depositary Shares","underlying_shares":73000},"source":{"system":"sec-edgar","filing":"0000899243-22-024328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924322024328/doc4.xml","form_type":"4"}},{"id":2303381,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2022-04-05T20:05:35.000Z","date":"2022-04-01","kind":"exercise","acquired":false,"shares":1010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer."}],"balance_after":4040,"derivative":{"underlying":"American Depositary Shares","underlying_shares":1010},"source":{"system":"sec-edgar","filing":"0000899243-22-013699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924322013699/doc4.xml","form_type":"4"}},{"id":2303380,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2022-04-05T20:05:35.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":16692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer."}],"balance_after":16692,"derivative":{"underlying":"American Depositary Shares","underlying_shares":16692},"source":{"system":"sec-edgar","filing":"0000899243-22-013699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924322013699/doc4.xml","form_type":"4"}},{"id":2303379,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-05T20:05:35.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":87699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Stock Options are exercisable for ADSs. The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Options vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer."}],"balance_after":87699,"derivative":{"exercise_price":45.47,"expiration_date":"2032-04-01","underlying":"American Depositary Shares","underlying_shares":87699},"source":{"system":"sec-edgar","filing":"0000899243-22-013699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924322013699/doc4.xml","form_type":"4"}},{"id":2303378,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2022-04-05T20:05:35.000Z","date":"2022-04-01","kind":"exercise","acquired":true,"shares":1010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer."}],"balance_after":25107,"source":{"system":"sec-edgar","filing":"0000899243-22-013699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924322013699/doc4.xml","form_type":"4"}},{"id":2455949,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2021-12-30T21:18:50.000Z","date":"2021-12-29","kind":"tax_withholding","acquired":false,"shares":5903,"price":69.23,"value":408664.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were disposed of through a netting transaction to the issuer to cover taxes due."}],"balance_after":24097,"source":{"system":"sec-edgar","filing":"0001567619-21-022691","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921022691/doc1.xml","form_type":"4"}},{"id":2458353,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Ordinary Shares","published_at":"2021-12-27T14:36:44.000Z","date":"2021-12-21","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0000899243-21-049736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924321049736/doc4.xml","form_type":"4"}},{"id":2572855,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-09-10T20:17:35.000Z","date":"2021-09-09","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The options vest in equal annual installments over four years beginning on 5/12/2018, the first anniversary of the date of grant."}],"balance_after":13334,"derivative":{"exercise_price":3,"expiration_date":"2027-05-12","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-21-016964","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016964/doc1.xml","form_type":"4"}},{"id":2572854,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-10T20:17:35.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":500,"price":146.61,"value":73305.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Reflects a weighted average sale price of $146.61 per share, at prices ranging from $146.50 to $146.76 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-016964","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016964/doc1.xml","form_type":"4"}},{"id":2572853,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-10T20:17:35.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":1400,"price":146.07,"value":204498.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects a weighted average sale price of $146.07 per share, at prices ranging from $145.49 to $146.46 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001567619-21-016964","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016964/doc1.xml","form_type":"4"}},{"id":2572852,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-10T20:17:35.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":800,"price":144.35,"value":115480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects a weighted average sale price of $144.35 per share, at prices ranging from $144.09 to $144.99 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1900,"source":{"system":"sec-edgar","filing":"0001567619-21-016964","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016964/doc1.xml","form_type":"4"}},{"id":2572851,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-10T20:17:35.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":1600,"price":143.34,"value":229344.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Reflects a weighted average sale price of $143.34 per share, at prices ranging from $142.81 to $143.72 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2700,"source":{"system":"sec-edgar","filing":"0001567619-21-016964","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016964/doc1.xml","form_type":"4"}},{"id":2572850,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-10T20:17:35.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":700,"price":141.92,"value":99344.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects a weighted average sale price of $141.92 per share, at prices ranging from $141.47 to $142.30 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4300,"source":{"system":"sec-edgar","filing":"0001567619-21-016964","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016964/doc1.xml","form_type":"4"}},{"id":2572849,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-10T20:17:35.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":800,"price":140.87,"value":112696.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects a weighted average sale price of $140.87 per share, at prices ranging from $140.47 to $141.26 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001567619-21-016964","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016964/doc1.xml","form_type":"4"}},{"id":2572848,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-10T20:17:35.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":569,"price":139.27,"value":79244.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects a weighted average sale price of $139.27 per share, at prices ranging from $139.05 to $139.36 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5800,"source":{"system":"sec-edgar","filing":"0001567619-21-016964","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016964/doc1.xml","form_type":"4"}},{"id":2572847,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-10T20:17:35.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":900,"price":138.33,"value":124497.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects a weighted average sale price of $138.33 per share, at prices ranging from $137.89 to $138.67 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6369,"source":{"system":"sec-edgar","filing":"0001567619-21-016964","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016964/doc1.xml","form_type":"4"}},{"id":2572846,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-10T20:17:35.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":2731,"price":137.39,"value":375212.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects a weighted average sale price of $137.39 per share, at prices ranging from $136.81 to $137.74 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":7269,"source":{"system":"sec-edgar","filing":"0001567619-21-016964","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016964/doc1.xml","form_type":"4"}},{"id":2572845,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-10T20:17:35.000Z","date":"2021-09-09","kind":"exercise","acquired":true,"shares":10000,"price":3,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001567619-21-016964","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016964/doc1.xml","form_type":"4"}},{"id":2575561,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-09-09T01:02:13.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest in equal annual installments over four years beginning on 5/12/2018, the first anniversary of the date of grant."}],"balance_after":23334,"derivative":{"exercise_price":3,"expiration_date":"2027-05-12","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-21-016870","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016870/doc1.xml","form_type":"4"}},{"id":2575560,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-09T01:02:13.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":800,"price":152.11,"value":121688.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects a weighted average sale price of $152.11 per share, at prices ranging from $151.85 to $152.50 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-016870","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016870/doc1.xml","form_type":"4"}},{"id":2575559,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-09T01:02:13.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":6600,"price":151.28,"value":998448.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects a weighted average sale price of $151.28 per share, at prices ranging from $150.84 to $151.82 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001567619-21-016870","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016870/doc1.xml","form_type":"4"}},{"id":2575558,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-09T01:02:13.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":2000,"price":150.41,"value":300820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects a weighted average sale price of $150.41 per share, at prices ranging from $149.80 to $150.78 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":7400,"source":{"system":"sec-edgar","filing":"0001567619-21-016870","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016870/doc1.xml","form_type":"4"}},{"id":2575557,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-09T01:02:13.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":300,"price":148.69,"value":44607.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects a weighted average sale price of $148.69 per share, at prices ranging from $148.23 to $148.92 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":9400,"source":{"system":"sec-edgar","filing":"0001567619-21-016870","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016870/doc1.xml","form_type":"4"}},{"id":2575556,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-09T01:02:13.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":200,"price":146.98,"value":29396.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects a weighted average sale price of $146.98 per share, at prices ranging from $146.66 to $147.30 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":9700,"source":{"system":"sec-edgar","filing":"0001567619-21-016870","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016870/doc1.xml","form_type":"4"}},{"id":2575555,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-09T01:02:13.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":100,"price":143,"value":14300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":9900,"source":{"system":"sec-edgar","filing":"0001567619-21-016870","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016870/doc1.xml","form_type":"4"}},{"id":2575554,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-09T01:02:13.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":10000,"price":3,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001567619-21-016870","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016870/doc1.xml","form_type":"4"}},{"id":2590446,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-25T21:47:06.000Z","date":"2021-08-24","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":17.99,"expiration_date":"2028-11-16","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001567619-21-016336","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016336/doc1.xml","form_type":"4"}},{"id":2590445,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-25T21:47:06.000Z","date":"2021-08-23","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant."}],"balance_after":38000,"derivative":{"exercise_price":17.99,"expiration_date":"2028-11-16","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001567619-21-016336","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016336/doc1.xml","form_type":"4"}},{"id":2590444,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-25T21:47:06.000Z","date":"2021-08-24","kind":"sale","acquired":false,"shares":8000,"price":143.36,"value":1146880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-016336","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016336/doc1.xml","form_type":"4"}},{"id":2590443,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-25T21:47:06.000Z","date":"2021-08-24","kind":"exercise","acquired":true,"shares":8000,"price":17.99,"value":143920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001567619-21-016336","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016336/doc1.xml","form_type":"4"}},{"id":2590442,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-25T21:47:06.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":8000,"price":135,"value":1080000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-016336","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016336/doc1.xml","form_type":"4"}},{"id":2590441,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-25T21:47:06.000Z","date":"2021-08-23","kind":"exercise","acquired":true,"shares":8000,"price":17.99,"value":143920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001567619-21-016336","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921016336/doc1.xml","form_type":"4"}},{"id":2632909,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-07-16T00:05:45.000Z","date":"2021-07-14","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant."}],"balance_after":46000,"derivative":{"exercise_price":17.99,"expiration_date":"2028-11-16","underlying":"Ordinary Shares","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001567619-21-013527","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921013527/doc1.xml","form_type":"4"}},{"id":2632908,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-07-16T00:05:45.000Z","date":"2021-07-14","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal annual installments over five years beginning on 09/20/2018, the first anniversary of the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":18,"expiration_date":"2027-09-20","underlying":"Ordinary Shares","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001567619-21-013527","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921013527/doc1.xml","form_type":"4"}},{"id":2632907,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-07-16T00:05:45.000Z","date":"2021-07-13","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal annual installments over five years beginning on 09/20/2018, the first anniversary of the date of grant."}],"balance_after":44000,"derivative":{"exercise_price":18,"expiration_date":"2027-09-20","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001567619-21-013527","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921013527/doc1.xml","form_type":"4"}},{"id":2632906,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-16T00:05:45.000Z","date":"2021-07-14","kind":"sale","acquired":false,"shares":4000,"price":169.11,"value":676440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-013527","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921013527/doc1.xml","form_type":"4"}},{"id":2632905,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-16T00:05:45.000Z","date":"2021-07-14","kind":"exercise","acquired":true,"shares":4000,"price":17.99,"value":71960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001567619-21-013527","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921013527/doc1.xml","form_type":"4"}},{"id":2632904,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-16T00:05:45.000Z","date":"2021-07-14","kind":"sale","acquired":false,"shares":4000,"price":169.11,"value":676440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-013527","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921013527/doc1.xml","form_type":"4"}},{"id":2632903,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-16T00:05:45.000Z","date":"2021-07-14","kind":"exercise","acquired":true,"shares":4000,"price":18,"value":72000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001567619-21-013527","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921013527/doc1.xml","form_type":"4"}},{"id":2632902,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-16T00:05:45.000Z","date":"2021-07-13","kind":"sale","acquired":false,"shares":8000,"price":169.92,"value":1359360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-013527","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921013527/doc1.xml","form_type":"4"}},{"id":2632901,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-16T00:05:45.000Z","date":"2021-07-13","kind":"exercise","acquired":true,"shares":8000,"price":18,"value":144000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001567619-21-013527","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921013527/doc1.xml","form_type":"4"}},{"id":2662701,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-18T00:04:48.000Z","date":"2021-06-17","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in equal annual installments over five years beginning on 09/20/2018, the first anniversary of the date of grant."}],"balance_after":52000,"derivative":{"exercise_price":18,"expiration_date":"2027-09-20","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001567619-21-012383","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921012383/doc1.xml","form_type":"4"}},{"id":2662700,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-18T00:04:48.000Z","date":"2021-06-16","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant."}],"balance_after":60000,"derivative":{"exercise_price":20.9,"expiration_date":"2028-03-28","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001567619-21-012383","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921012383/doc1.xml","form_type":"4"}},{"id":2662699,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-06-18T00:04:48.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":8000,"price":161.64,"value":1293120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-012383","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921012383/doc1.xml","form_type":"4"}},{"id":2662698,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-06-18T00:04:48.000Z","date":"2021-06-17","kind":"exercise","acquired":true,"shares":8000,"price":18,"value":144000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001567619-21-012383","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921012383/doc1.xml","form_type":"4"}},{"id":2662697,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-06-18T00:04:48.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":8000,"price":162.71,"value":1301680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-012383","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921012383/doc1.xml","form_type":"4"}},{"id":2662696,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-06-18T00:04:48.000Z","date":"2021-06-16","kind":"exercise","acquired":true,"shares":8000,"price":20.9,"value":167200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001567619-21-012383","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921012383/doc1.xml","form_type":"4"}},{"id":2694587,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-05-27T00:18:30.000Z","date":"2021-05-25","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant."}],"balance_after":68000,"derivative":{"exercise_price":20.9,"expiration_date":"2028-03-28","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001567619-21-011217","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921011217/doc1.xml","form_type":"4"}},{"id":2694586,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-05-27T00:18:30.000Z","date":"2021-05-24","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant."}],"balance_after":76000,"derivative":{"exercise_price":20.9,"expiration_date":"2028-03-28","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001567619-21-011217","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921011217/doc1.xml","form_type":"4"}},{"id":2694585,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-27T00:18:30.000Z","date":"2021-05-25","kind":"sale","acquired":false,"shares":8000,"price":161.66,"value":1293280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-011217","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921011217/doc1.xml","form_type":"4"}},{"id":2694584,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-27T00:18:30.000Z","date":"2021-05-25","kind":"exercise","acquired":true,"shares":8000,"price":20.9,"value":167200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001567619-21-011217","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921011217/doc1.xml","form_type":"4"}},{"id":2694583,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-27T00:18:30.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":8000,"price":162.37,"value":1298960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-011217","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921011217/doc1.xml","form_type":"4"}},{"id":2694582,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-27T00:18:30.000Z","date":"2021-05-24","kind":"exercise","acquired":true,"shares":8000,"price":20.9,"value":167200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001567619-21-011217","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921011217/doc1.xml","form_type":"4"}},{"id":2742688,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-04-21T23:59:56.000Z","date":"2021-04-21","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant."}],"balance_after":84000,"derivative":{"exercise_price":20.9,"expiration_date":"2028-03-28","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001567619-21-008429","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921008429/doc1.xml","form_type":"4"}},{"id":2742687,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-04-21T23:59:56.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant."}],"balance_after":92000,"derivative":{"exercise_price":20.9,"expiration_date":"2028-03-28","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001567619-21-008429","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921008429/doc1.xml","form_type":"4"}},{"id":2742686,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-04-21T23:59:56.000Z","date":"2021-04-21","kind":"sale","acquired":false,"shares":8000,"price":161.99,"value":1295920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-008429","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921008429/doc1.xml","form_type":"4"}},{"id":2742685,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-04-21T23:59:56.000Z","date":"2021-04-21","kind":"exercise","acquired":true,"shares":8000,"price":20.9,"value":167200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001567619-21-008429","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921008429/doc1.xml","form_type":"4"}},{"id":2742684,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-04-21T23:59:56.000Z","date":"2021-04-20","kind":"sale","acquired":false,"shares":8000,"price":150.2,"value":1201600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-008429","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921008429/doc1.xml","form_type":"4"}},{"id":2742683,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2021-04-21T23:59:56.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":8000,"price":20.9,"value":167200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001567619-21-008429","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000156761921008429/doc1.xml","form_type":"4"}},{"id":2756615,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Share Units","published_at":"2021-04-06T01:54:09.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":5050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit represents a contingent right to receive one Ordinary Share of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."}],"balance_after":5050,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5050},"source":{"system":"sec-edgar","filing":"0000899243-21-014995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924321014995/doc4.xml","form_type":"4"}},{"id":2756614,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":89464,"kind":"person","name":"Reinhart Harald","position":1,"cik":"0001835824","reported_name":"Reinhart Harald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-04-06T01:54:09.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":26650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Options vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant."}],"balance_after":26650,"derivative":{"exercise_price":130.96,"expiration_date":"2031-04-01","underlying":"Ordinary Shares","underlying_shares":26650},"source":{"system":"sec-edgar","filing":"0000899243-21-014995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704292/000089924321014995/doc4.xml","form_type":"4"}}]}